drugset / Trial / NCT00200850
Immunotherapy Administered Under the Tongue to Treat Dust Mite Allergy
Completed
31 enrolled
University of Wisconsin, Madison
National Center for Complementary and Integrative Health (NCCIH) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will investigate sublingual immunotherapy (SLIT), a treatment involving antigens placement under the tongue to help asthma sufferers build a tolerance to the allergy-causing substances. Specifically, this study will determine the effectiveness of SLIT at two different dosing regimens for patients with intermittent mild asthma caused by dust mites.
Timeline
- Start
- 2006-01
- Primary completion
- 2008-10
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | House Dust Mite SLIT | Vaccine | 143 unknown | Other |
| Comparator | House Dust Mite SLIT | Vaccine | 10000 unknown | Other |